BEBPA Blog

2017 Use of DOE for Bioassay Development (PDF)

View the PDF below.

Post navigation

PreviousPrevious post:Assay Acceptance Criteria for Multiwell-Plate–Based Biological Potency Assays (PDF)NextNext post:2018 Host Cell Protein Analysis in Biologic Drug Development – BioAnalytix (PDF)

Welcome to the BioPharmaceutical Emerging Best Practices Association (BEBPA), a non-profit organization managed by and for the benefit of the biopharmaceutical scientific community. Our focus is to provide a platform for industrial scientists to discuss common technical problems, suggest potential solutions and openly discuss the merits of such solutions. ABOUT US

BEBPA CONFERENCES

2025 US BIOASSAY CONFERENCE
March 24-26, 2025 ● Tucson, AZ, USA ● Hybrid Conference ● REGISTER NOW!
2024 HCP CONFERENCE
May 11-16, 2024 ● College Park, MD,, USA ● Hybrid Conference ● REGISTER NOW!
2024 EUR BIOASSAY CONFERENCE
25-27 September 2024 ● Prague, Czech Republic ● Hybrid Conference ● REGISTER NOW!

STAY CONNECTED

OFFICE ADDRESS
P.O. Box 4458 Bremerton, WA 98312
OFFICE PHONE
206-651-4542
EMAIL ADDRESS
Click Here to directly send an e-mail to BEBPA

Find us on:

Facebook page opens in new window X page opens in new window Linkedin page opens in new window Instagram page opens in new window Mail page opens in new window

Privacy Policy
Terms of Use
Conferences
Contact

Footer Menu

Go to Top

DON’T MISS OUT!

Subscribe to BEBPA Technical Notes

Be the first to get latest updates and exclusive content straight to your email inbox.

Email

Stay Updated

Give it a try, you can unsubscribe anytime.

Our website uses cookies and other similar technologies to improve our site and your online experience. By continuing to use our website you consent to cookies being used. See our Privacy Policy to find out more.Ok View Our Privacy Policy

BEBPA Blog

2017 Use of DOE for Bioassay Development (PDF)

Related Posts